research
-
A scientist’s opinion: Interview with Gyöngyi Kovacs about the EU Project HERoS
Interview with Gyöngyi Kovacs, Erkko Professor in Humanitarian Logistics at the Hanken School of Economics (Finland) and coordinator of the EU-funded Health Emergency Response in Interconnected Systems project. What inspired the Health Emergency Response in Interconnected Systems (HERoS) project?... -
HERoS: How can we improve our response to health emergencies?
A European research consortium (HERoS) was set up to learn from the present COVID-19 pandemic and to provide decision-makers with the necessary information and tools to more efficiently and effectively respond to future disease outbreaks. Some outcomes of this collaboration include a tool to optimise...
-
ESMH Media Review – April 8, 2021
Climate change, Covid-19 & EU research funds: check out the ESMH selection of 24 science and tech news published in the last weeks on the web.
-
Professor Heidi Larson: "This is a key moment to build trust in countries and socio-economic groups with relatively low confidence in vaccines."
For over a decade, Heidi Larson, Professor of Anthropology, Risk and Decision Science at the London School of Hygiene & Tropical Medicine, has been leading global efforts to monitor public confidence in immunisation programmes. As COVID-19 vaccination programmes are rolled out across the EU, this is... -
An expert’s opinion: An interview with Ludo Waltman on the surge in COVID-19 research papers
We speak with Ludo Waltman, Professor of Quantitative Science Studies and Deputy Director of the Centre for Science and Technology Studies (CWTS) at Leiden University, on how the COVID-19 pandemic is changing the way we assess the quality of scientific literature. What are you working on at the moment?... -
An expert’s opinion: An interview with Adam Marcus on scientific publishing in times of COVID-19
Adam Marcus, Co-founder of Retraction Watch and managing editor of Gastroenterology & Endoscopy News, highlights the need to be vigilant about the quality of COVID-19 research papers and encourages publishers to publish fewer but better-quality papers. How many COVID-19 papers have been retracted... -
Covid-19: What are the consequences of the unprecedented rush for knowledge?
The surge in COVID-19 research papers has put the spotlight on the peer review process and is changing the way we assess the quality of scientific literature.
-
Tocilizumab : a treatment alternative in COVID-19 pneumonia
Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.